TSHA — TAYSHA GENE THERAPIES INC

Ownership history in B Group, Inc. · 5 quarters on record

This page tracks every 13F SEC filing in which B Group, Inc. reported a position in TAYSHA GENE THERAPIES INC (TSHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

7.31% (2025 Q4)

Avg. % of fund

3.47%

First filed

2024 Q4

Last filed

2025 Q4

Quarters held

5

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	1,800,556	—	0%	7.31%	$9.9M	$5.50
2025 Q3	UNCHANGED	1,800,556	—	0%	4.33%	$5.9M	$3.27
2025 Q2	ADDED	1,800,556	+545,000	+43.4%	3.20%	$4.2M	$2.31
2025 Q1	ADDED	1,255,556	+290,000	+30.0%	1.50%	$1.7M	$1.39

% of Fund (quarterly) TSHA price (monthly, adj. close)

Other funds also holding TSHA

As of 2025 Q4 — sorted by position size

Octagon Capital Advisors LP 3Y 5.92% GordonMD Global Investments LP 5.25% SUPERSTRING CAPITAL MANAGEMENT LP 2.89% Ally Bridge Group (NY) LLC 3Y 2.86% Ally Bridge Group (NY) LLC 3Y 2.62% Vestal Point Capital, LP 2.57% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.7% Siren, L.L.C. 1.66% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.33% Quantum Private Wealth, LLC 3Y 1.32%

← Back to B Group, Inc. Holdings